CVRx EBITDA 2021-2025 | CVRX
CVRx ebitda from 2021 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| CVRx Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $-59 |
| 2023 | $-42 |
| 2022 | $-42 |
| 2021 | $-26 |
| 2020 | $-11 |
| CVRx Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-06-30 | $-14 |
| 2025-03-31 | $-13 |
| 2024-12-31 | $-10 |
| 2024-09-30 | $-13 |
| 2024-06-30 | $-14 |
| 2024-03-31 | $-22 |
| 2023-12-31 | $-9 |
| 2023-09-30 | $-9 |
| 2023-06-30 | $-12 |
| 2023-03-31 | $-12 |
| 2022-12-31 | $-11 |
| 2022-09-30 | $-10 |
| 2022-06-30 | $-11 |
| 2022-03-31 | $-10 |
| 2021-12-31 | $-9 |
| 2021-09-30 | $-7 |
| 2021-06-30 | $-6 |
| 2021-03-31 | $-4 |
| 2020-12-31 | |
| 2020-09-30 | $-3 |
| 2020-06-30 | $-3 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.195B | $0.051B |
| CVRx Inc. is a commercial-stage medical device company. It focused on developing, manufacturing and commercializing neuromodulation solutions for patients with cardiovascular diseases. CVRx Inc. is headquartered in Minneapolis, MN. | |||